Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized Phase IIa, Multi-center, Double-blind, Placebo-controlled Study to Assess the Safety, Feasibility, Tolerability, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease

Next Previous
X
Search
Trial Profile

A Randomized Phase IIa, Multi-center, Double-blind, Placebo-controlled Study to Assess the Safety, Feasibility, Tolerability, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 04 Jul 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Montelukast (Primary)
  • Indications Alzheimer's disease
  • Focus Proof of concept; Registrational; Therapeutic Use
  • Acronyms BUENA
  • Sponsors IntelGenx Corp.

    • Most Recent Events

    • 03 Jul 2024 According to an IntelGenx Technologies media release, final study report, which includes the analysis of all safety and efficacy information, is planned for completion and release at the beginning of third quarter 2024, company has obtained the outcome of a topline analysis of the efficacy data from the BUENA study.
    • 03 Jul 2024 Results published in the IntelGenx Technologies Media Release.
    • 17 Apr 2024 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top